International Study for Treatment of High Risk Childhood Relapsed ALL 2010



Improvement in the rates of complete remission (CR) in HR ALL relapse patients

Main inclusion criteria

  • Morphologically confirmed diagnosis of 1st relapsed precursor B-cell or T-cell ALL
  • Children less than 18 years of age at date of inclusion into the study
  • Meeting HR criteria (any T BM relapse, early/very early isolated BM relapse, very early isolated/combined extramedullary relapse)
  • Karnofsky oder Lansky > 50


Charité Berlin

Diese Webseite verwendet Cookies. Durch die Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Datenschutzinformationen